Synergistic Clot Manipulation and Removal System

A novel, AI-driven, IoT-enabled, blockchain-secured, and nanomaterial-enhanced system for robotically controlled clot manipulation and removal, integrating multiple distinct technologies to create a more powerful and effective treatment solution.

The original patent addressed the need for robotically controlled clot manipulation and removal, but was limited by its reliance on manual operation and lack of integration with advanced technologies. The new inventive concept solves this problem by combining the original patented system with AI, IoT, blockchain, and nanomaterials to create a more efficient, secure, and personalized treatment approach.

The synergistic clot manipulation and removal system comprises a robotic arm with a clot-manipulation instrument, integrated with an AI-driven clot analysis module for predicting clot behavior, an IoT-enabled sensor module for monitoring patient vital signs, a blockchain-based secure data storage module for storing patient-specific clot data, and a nanomaterial-based clot-dissolving agent delivery module. The system utilizes machine learning-based patient risk assessment to predict patient-specific clot formation risks and provide personalized treatment recommendations. The real-time imaging module monitors clot dissolution, while the cloud-based data analytics module tracks procedure outcomes.

The new claims introduce the novel combination of AI, IoT, blockchain, and nanomaterials with the original patented system, providing an inventive step beyond the original patent. The integration of these distinct technologies enables a more powerful, efficient, and personalized treatment approach, which is not obvious from the original patent.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT sensor configurations, blockchain protocols, or nanomaterials. Variations could also include the integration of additional technologies, such as augmented reality or 5G networks, to further enhance the system's capabilities.

The synergistic clot manipulation and removal system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and neurovascular treatment. The system's ability to provide personalized, efficient, and secure treatment solutions could disrupt the current market and create new opportunities for growth and innovation.